arrow
C

Conor Steuer

Emory University
H指数:35
被引数:6,472

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Minimizing Chemoradiation Using a Surgical Algorithm for HPV-Associated Cancer of Unknown Primary

采用手术算法最小化HPV相关未知原发灶癌症的化放疗

2025-12-010
PRE
Reirradiation: Standards, challenges, and patient-focused strategies across tumor types

再照射:标准、挑战及跨肿瘤类型的患者中心策略

2025-05-290
OAAI
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial (vol 29, pg 880, 2023)
2024-07-021
PRE
Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non-small cell lung cancer

黑人局部晚期非小细胞肺癌患者同步放化疗后durvalumab的安全性和有效性

CANCER
IF5.1
2023-06-242
PRE
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
2023-04-0331
OA
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era

辐射剂量对durvalumab时代不可切除或III期非小细胞肺癌中免疫细胞的影响

2022-09-0121
PRE
KontRASt: A Phase Ib/II, open-label, multi-center, dose-escalation study of JDQ443 in patients with advanced solid tumors harboring the KRAS G12C mutation
2021-12-012
PRE
NEMVALEUKIN ALFA, A NOVEL ENGINEERED IL-2 CYTOKINE, IN COMBINATION WITH THE ANTI-PD-1 ANTIBODY PEMBROLIZUMAB IN PATIENTS WITH RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (ION-01 STUDY)
2021-11-103
OA
Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus
2021-07-0112
OAAI